Jasper Therapeutics

Forecast & Rating5 analysts currently cover Jasper Therapeutics, with about 40.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $9.17, about 1231.6% upside from the current price of $0.69. Price targets range from $1.50 to $20.00 — a wide spread, showing clear disagreement over just how much Jasper Therapeutics can rise. For you, this means institutional views on Jasper Therapeutics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 2, 2026; for reference only and not investment advice.